FGFR1-TACC1 fusion associated with malignant transformation in a primary spinal cord glioma: a case report

• Published in: Journal of spine surgery (Hong Kong) 2021-09, Vol.7 (3), p.434-438
• Main Authors: Asuzu, David T., Desai, Bhargav, Maggio, Dominic, Mandell, James, Ray-Chaudhury, Abhik, Abdullaev, Zied, Aldape, Kenneth, Heiss, John, Buchholz, Avery L.
• Format: Article
• Language: English
• Subjects: Case Report
• ISSN: 2414-469X; 2414-4630
• DOI: 10.21037/jss-21-24

Molecular mechanisms of malignant transformation in spinal cord gliomas are not well-understood. Our objective was to investigate genetic causes of malignant transformation in a primary spinal cord glioma. A 32-year-old female patient presented with bilateral lower extremity weakness and was diagnosed with a primary spinal cord glioma from T9 to T12, with a syrinx extending from the craniocervical junction to the conus. She underwent resection in 2006. Pathology showed an abundance of Rosenthal fibers, calcification and degenerative features consistent with a low-grade pilocytic astrocytoma. She presented in 2020 with tumor recurrence and underwent re-resection. Whole exome sequencing, DNA methylation profiling and immunohistochemistry were performed on her initial and recurrent tumor samples. Immunohistochemical profiling of her recurrent tumor showed pleomorphic cells with extensive necrosis consistent with a high-grade glioma. DNA methylation profiling showed that the initial tumor clustered with pilocytic astrocytomas, whereas the recurrent lesion clustered with anaplastic astrocytomas, confirming malignant transformation. Whole-exome sequencing showed interim acquisition of a rare fibroblast growth factor receptor-transforming acidic coiled-coil ( FGFR1-TACC1 ) gene fusion. We report an FGFR1-TACC1 fusion associated with malignant transformation in a primary spinal cord glioma. Our study adds to growing reports of FGFR-TACC fusions, which are amenable to receptor tyrosine kinase inhibition.